Ipamorelin is a synthetic pentapeptide — a peptide composed of five amino acids — that belongs to the growth hormone secretagogue family of research compounds. It was first described in the scientific literature in 1998 and was developed as a selective tool for activating the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R. The compound has been used in laboratory and animal-model research as a probe for studying growth hormone release biology and the GHS-R signaling system. It is supplied as a research peptide for laboratory and analytical use only and is not an approved medicine, supplement, or therapy in any jurisdiction.

What does 'growth hormone secretagogue' mean?

A secretagogue is a substance that causes another substance to be released. A growth hormone secretagogue, then, is a compound that causes growth hormone to be released — typically from the pituitary gland, where growth hormone is stored and released into the bloodstream. The term covers a range of compounds, including the GHRP family that Ipamorelin belongs to and the broader category of GHS-R agonists. Growth hormone-releasing hormone analogs are sometimes also included in the broader secretagogue conversation, although they work through a different receptor. The label describes the functional effect rather than a single chemical category.

How is Ipamorelin different from older GHRPs like GHRP-6 or GHRP-2?

Ipamorelin shares the general mechanism of older GHRPs — activation of the GHS-R / ghrelin receptor on pituitary somatotrophs — but was developed with the specific goal of cleaner selectivity. Older GHRPs like GHRP-6 and GHRP-2 produce measurable effects not only on growth hormone release but also on prolactin, cortisol, and ACTH release in the laboratory and animal-model systems where they have been studied. The original 1998 Ipamorelin publication reported a more focused effect on growth hormone release with less spillover into these other pituitary hormones. This selectivity profile is part of why Ipamorelin has remained a popular tool in basic research on growth hormone biology.

What is the ghrelin receptor?

The ghrelin receptor is a G-protein-coupled receptor known formally as the growth hormone secretagogue receptor, or GHS-R. It is the natural receptor for the hormone ghrelin, which is produced primarily by cells in the stomach. The receptor is expressed on the somatotrophs of the anterior pituitary gland — the cells responsible for growth hormone production and release — and also in parts of the brain and the gastrointestinal tract. When ghrelin or a synthetic agonist like Ipamorelin binds to GHS-R, the receptor activates an intracellular signaling cascade that culminates in growth hormone release in the pituitary or in other effects in other tissues where the receptor is expressed.

Is Ipamorelin growth hormone?

No. Ipamorelin is not growth hormone. Growth hormone is a much larger protein hormone produced and released by the pituitary gland. Ipamorelin is a small synthetic pentapeptide that binds to a receptor — the GHS-R — and in laboratory and animal-model studies, that binding has been shown to cause growth hormone release from the pituitary. The relationship is that Ipamorelin is studied as a release-stimulating tool, not as a substitute for growth hormone itself. The two compounds belong to entirely different categories: one is a small synthetic peptide and the other is a large pituitary hormone produced as a biologic when used in approved medical contexts.

How is Ipamorelin different from Sermorelin or CJC-1295?

Sermorelin and CJC-1295 are growth hormone-releasing hormone analogs, meaning they are designed to mimic the natural action of GHRH at its receptor on the pituitary. Ipamorelin is a growth hormone-releasing peptide that acts on a different receptor — the GHS-R / ghrelin receptor — on the same pituitary cells. Both ultimately influence growth hormone release, but they do so through distinct pathways. Some research has explored combining a GHRH analog with a GHRP because the two pathways can interact at the pituitary. Despite this overlap, the compounds are not interchangeable, and the literature on each should be read with its specific mechanism in mind.

Has Ipamorelin been studied in humans?

Ipamorelin has appeared in some clinical-research investigations exploring potential indications, but the compound did not become an approved medicine in any major regulatory jurisdiction. The bulk of the available scientific literature on Ipamorelin sits within preclinical research — cell-culture systems, isolated tissue preparations, and animal models. There is no large body of randomized clinical-trial evidence in humans that would establish Ipamorelin as a recognized treatment for any condition. Any reading of the compound needs to keep this distinction clearly in mind and avoid extrapolating from preclinical observations to claims about effects in people.

Why does growth hormone release naturally happen in pulses?

Growth hormone release from the pituitary follows a pulsatile pattern, with the largest pulses typically occurring during deep sleep and additional pulses scattered throughout the day. This pulsatile pattern appears to be biologically meaningful — the downstream effects of growth hormone on target tissues seem to depend partly on the pulse pattern rather than just the total amount released. The pulses are produced by the coordinated activity of upstream regulators, including GHRH and the inhibitory hormone somatostatin, which interact at the level of the pituitary. The natural pulsatile pattern is one of the systems that pharmacological tools like Ipamorelin are used to probe in laboratory research.

What is the amino acid sequence of Ipamorelin?

The sequence of Ipamorelin is Aib-His-D-2-Nal-D-Phe-Lys-NH2. Two of the amino acids are D-amino acids, which are mirror-image versions of the more common L-form found in normal human proteins. The use of D-amino acids in synthetic peptide design is a common strategy for increasing resistance to enzymatic breakdown and for fine-tuning receptor interactions. The sequence also includes alpha-aminoisobutyric acid (Aib), a non-standard amino acid that influences chain conformation, and the C-terminus is amidated. These features collectively reflect the deliberate medicinal-chemistry approach that went into the compound's original design.

Is Ipamorelin a steroid?

No. Ipamorelin is a peptide, not a steroid. Steroids are a chemically distinct family of molecules built around a four-ring carbon structure. Peptides are short chains of amino acids and have no structural relationship to steroid compounds. The confusion between peptides and steroids in popular conversation usually reflects the broader confusion between different categories of compounds discussed in performance or research contexts. Scientifically, the two categories have nothing in common in terms of chemistry, mechanism, or biological lineage, and they should not be grouped together. Ipamorelin's mechanism, through GHS-R activation, has no overlap with the mechanisms of steroid compounds.

What are D-amino acids and why are they in Ipamorelin?

Amino acids exist in two mirror-image forms, called L and D. The L-form is what is overwhelmingly used in the proteins of living organisms; the D-form is structurally a mirror image. Most enzymes that break down peptides recognize specific L-amino acid sequences and have difficulty acting on chains containing D-amino acids at key positions. Incorporating D-amino acids into synthetic peptides is a well-established medicinal-chemistry strategy for increasing resistance to enzymatic degradation. Ipamorelin includes D-2-naphthyl-D-alanine and D-phenylalanine at specific positions, contributing to the compound's stability and to its specific binding interactions with the GHS-R receptor.

What is alpha-aminoisobutyric acid (Aib)?

Alpha-aminoisobutyric acid, usually abbreviated Aib, is a non-standard amino acid that does not appear in normal human proteins but is commonly used in synthetic peptide design. Its structure is similar to alanine but with an additional methyl group, which constrains the conformational flexibility of the peptide chain at the position where it is incorporated. This constraint can help stabilize particular structural elements and can influence how the peptide engages its target receptor. Aib is found at the amino terminus of Ipamorelin and is part of the deliberate design that gives the compound its specific pharmacological properties.

How is research-grade Ipamorelin manufactured?

Research-grade Ipamorelin is produced through solid-phase peptide synthesis using standard Fmoc protecting-group chemistry, with particular attention required for the incorporation of the non-standard D-amino acids and Aib. After synthesis, the peptide is cleaved from the solid support and purified by reversed-phase high-performance liquid chromatography. Identity is verified by mass spectrometry, and purity is reported as an HPLC percentage on the Certificate of Analysis. The finished material is lyophilized — freeze-dried — into a stable powder form for shipping and laboratory storage. The non-standard amino acids in the sequence make supplier-side analytical rigor particularly important.

How should research-grade Ipamorelin be stored?

General laboratory practice for short peptides like Ipamorelin is to keep the lyophilized powder sealed in its vial, away from light and moisture, at deep-freeze temperatures until needed. Once reconstituted in a buffer or solvent, the peptide's stability drops significantly. Many protocols recommend either prompt use of the solution or dividing it into smaller aliquots that can be frozen and thawed individually to minimize freeze-thaw damage. These are general handling principles for peptide research materials and should not be interpreted as instructions for any human use. Specific protocols should follow the supplier's documentation and the laboratory's standard operating procedures.

Is Ipamorelin considered safe?

Ipamorelin is a research compound rather than an approved medicine, and there is no formal human safety profile of the kind that exists for approved medications. The available preclinical literature includes safety-relevant observations from animal-model studies, and some clinical-research investigations have included tolerability assessments, but no regulatory body has certified the compound as safe for general human use. The educational discussion of Ipamorelin must acknowledge that human safety conclusions cannot be drawn from preclinical observations alone and that the compound is supplied for laboratory research only, not for personal use of any kind.

Why is Ipamorelin not a supplement?

Dietary supplements, in regulatory terms, are products made of ingredients recognized for human consumption. Ipamorelin is not recognized in any major regulatory framework as a dietary ingredient and has not been evaluated as a food component. It does not appear in the recognized lists of approved supplement components in the United States or comparable jurisdictions. The compound is sold and shipped for laboratory and analytical research only. Any presentation of Ipamorelin as a supplement, performance-enhancing product, or therapy would misrepresent its actual regulatory status and the way it is intended to be handled in legitimate research contexts.

What does selectivity mean in the context of Ipamorelin?

Selectivity in pharmacology refers to a compound's tendency to act on a specific target while having less effect on related but distinct targets. In Ipamorelin's case, selectivity refers to its reported ability to activate the GHS-R / ghrelin receptor pathway — leading to growth hormone release — without producing the same magnitude of effects on certain other pituitary hormones that some older GHRPs were known to influence. Selectivity is valuable in research because it allows investigators to attribute observed effects more cleanly to a single mechanism. Cleaner experimental tools generally produce cleaner experimental conclusions.

How does Ipamorelin compare with hexarelin?

Hexarelin is another member of the GHRP family. It shares the general mechanism of GHS-R / ghrelin receptor activation but has its own specific profile of effects and receptor interactions. In the broader comparative GHRP literature, hexarelin has been studied alongside Ipamorelin, GHRP-2, and GHRP-6 to map the differences in selectivity, signaling, and behavior across these related compounds. Researchers comparing the various GHRPs treat them as members of the same general category but with distinct fingerprints. Anyone reading deeply into the GHRP literature will encounter all of these compounds and will benefit from understanding the comparative context.

Does Ipamorelin affect appetite?

Ghrelin, the natural ligand for GHS-R, is known to play roles in appetite regulation, and some GHRPs that share the GHS-R activation mechanism have been associated with appetite-related observations in laboratory studies — particularly the older GHRP-6. Ipamorelin's reported selectivity profile may make its appetite-related effects less pronounced than those of some other GHRPs in the experimental systems studied. The literature on this specific question is more limited and largely preclinical, and any extension to human appetite biology would require clinical-research evidence that does not currently exist in a form that supports claims for individual use.

Where can I read primary scientific literature on Ipamorelin?

The original 1998 publication describing Ipamorelin in the European Journal of Endocrinology is a useful starting point. From there, PubMed and Google Scholar searches for terms like Ipamorelin, GHRP, ghrelin receptor, GHS-R, and growth hormone secretagogue will surface follow-up research, comparative GHRP studies, and reviews. The broader ghrelin biology literature, particularly the work following the 1999 identification of ghrelin by Kojima and colleagues, provides important context. Reading reviews alongside primary publications is one of the most efficient ways to understand the field's current state and the open questions that remain.

Ipamorelin (with Bacteriostatic Water) lyophilized vial with bacteriostatic water for research

Swiss-SourcedPharmaceutical-GradeLyophilized PowderIn Stock≥99% Purity

In Stock

Ipamorelin (with Bacteriostatic Water)

Name: Ipamorelin
Brand: Dr Jays Peptides
SKU: FC5647
Price: 20.00 USD
Availability: OutOfStock

In Stock — ships from Jacksonville, FL

Free shipping over $300 — you're $300.00 away

SKU: FC6097

$28.00

Volume pricing

·10 mg

Sitewide sale price — extra discount by quantity on this line

Quantity	Price / Unit	Discount
5–9	$26.60	5%
10–15	$25.20	10%
16–20	$23.80	15%
21+	$22.40	20%

Dosage10 mg

100% Satisfaction Guarantee — damaged, incorrect, or off-spec orders are made right with a free reship or refund.
Flat-rate 2-day shipping (when available) from Jacksonville, FL · free shipping insurance on every order · free over $300.
Bacteriostatic water included — the correct amount for reconstitution, in every order.
Sourced direct from our Swiss pharmaceutical-grade manufacturer · Batch-traceable · Veteran-owned · 20% of profits donated to animal charities.
Secure checkout — powered by Shopify.

Accepted:

ZelleStripeBankful

Research use only — not for human or veterinary consumption.

What you receive

Sealed, lyophilized vial — 10 mg
Bacteriostatic water — appropriate size for reconstitution, included free
Certificate of Analysis available — view COAs

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue that has been widely studied in endocrine and metabolic research for its interaction with ghrelin receptors (GHS-R1a). It is known for its receptor selectivity within the GHRP class and is frequently used in laboratory research investigating growth hormone release pathways and neuroendocrine signaling.

IpamorelinGHRPGrowth Hormone SecretagogueGHS-R1aLyophilized

Swiss-sourced · Pharmaceutical-grade · Cold-chain shipped

What researchers say

Real reviews from Dr Jays Peptides customers

Why Dr Jays vs. the alternatives

An honest side-by-side for researchers who care about what's in the vial

Purity guarantee

Dr Jays

98%+ guaranteed

Others

95–97% claimed

COA included with every order

Dr Jays

Others

Refund if purity fails

Dr Jays

Others

Same-Day shipping UPS

Cold storage — temperature controlled

Dr Jays

Others

Responsive human support

email reply in under 30 minutes

Dr Jays

Others

100% American made & sourced

Synthesized & fulfilled in the USA

Dr Jays

Others

Veteran owned & operated

Dr Jays

Others

Criteria	Dr Jays Peptides	Other peptide vendors
Purity guarantee	98%+ guaranteed	95–97% claimed
COA included with every order		~
Refund if purity fails
Same-Day shipping UPS Cold storage — temperature controlled
Responsive human support email reply in under 30 minutes		~
100% American made & sourced Synthesized & fulfilled in the USA
Veteran owned & operated